News

Press Releases

Press Releases to be coming soon

about Ablenio

Ablenio Biosciences LLC. is a publicly traded biotechnology company that has developed cutting-edge highly selective therapeutics for complement-mediated diseases.

Useful links
About UsOur ScienceR&D StrategyPartners
Navigate
Members LoginCareersContact UsNews
Copyright Ablenio Biosciences LLC.